Navigating breast cancer treatment for women of color
Effect of a Navigation Intervention on Care Equity for Women of Color Diagnosed With Breast Cancer: A Feasibility Study
This study is testing a new online tool to help women of color with non-metastatic breast cancer better understand their treatment options and get the care they need on time.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Northwestern University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06271356 on ClinicalTrials.gov |
What this trial studies
This study utilizes the BC-Navigate website and application developed by The Chrysalis Initiative to support women of color undergoing treatment for non-metastatic breast cancer. The program aims to enhance patient knowledge and self-advocacy, facilitating timely initiation of adjuvant chemotherapy. By focusing on Black and African American women, as well as other women of color, the study seeks to address health inequities in cancer care delivery. Participants will receive navigation and coaching to improve their treatment experience and outcomes.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 and older, diagnosed with non-metastatic breast cancer, who have not yet started their post-operative chemotherapy.
Not a fit: Men and patients with additional life-threatening conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly improve the quality of care and treatment outcomes for women of color with breast cancer.
How similar studies have performed: Other studies have shown promise in using patient navigation programs to improve cancer care, indicating a potential for success with this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age and older * Diagnosed with non-metastatic breast cancer (stages I-III) * An order placed for a post-operative chemotherapy cycle by a NM clinician * Not have initiated a recommended post-operative chemotherapy cycle at the time of study enrollment * Completed surgery for breast cancer * First-time diagnosis of breast cancer * Established care at Northwestern Medicine * English-speaking as the navigation website is not yet available in other languages * Access to internet on a smart phone or computer/tablet * Any ethnic background * We will only consider patients that sign an informed consent form Exclusion Criteria: * Men will be excluded because the navigation website only contains content and resources for women. Men also make up less than 1% of all breast cancer diagnoses and the Breast Cancer-Navigate app/website content was developed for female breast cancer patients. * Diagnosis of additional, life-threatening condition (e.g., end-stage renal disease, heart failure) which can interfere with timely planned adjuvant chemotherapy treatment for cancer.
Where this trial is running
Chicago, Illinois
- Northwestern University — Chicago, Illinois, United States (Recruiting)
Study contacts
- Study coordinator: Betina Yanez
- Email: betina.yanez@northwestern.edu
- Phone: 312-503-5341
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.